In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Additional contents from webparts:

Main Sponsor of EuroCMR 2012


Gold Sponsor of EuroCMR 2012



Overview and role of biopsy in myocarditis

Cristina BASSO | Padua, Italy


CMR to guide management of myocarditis

Matthias FRIEDRICH | Montreal, Canada


Quantification of fibrosis: tool or toy?

Andrew FLETT | London, UK


Outcome after myocarditis: emerging evidence of CMR

Oliver BRUDER | Essen, Germany

CMR methods for measuring the extracelluar volume in the heart

Peter KELLMAN | Bethesda, USA


Pre-clinical insights and validation of T1 and extracelluar volume mapping

Martin UGANDER | Stockholm, Sweden


Clinical application of T1 and extracelluar volume mapping

Andrew ARAI | Bethesda, USA

The emerging role of mapping relaxation times

Matthias FRIEDRICH | Montreal, Canada

Where CMR has changed clinical practice

Frank RADEMAKERS | Leuven, Belgium


Late-breaking data from the EuroCMR registry

Oliver BRUDER | Essen, Germany


Recent and ongoing imaging trials that can change clinical practice

John GREENWOOD | Leeds, UK


New CMR methods that will impact clinical practice within 5 years

Jürg SCHWITTER | Lausanne, Switzerland

Welcome Address

Herbert FRANK | Tulln, Austria